Introduction The FDA’s Breakthrough Designation Devices (BDD) Program, established under the 21st Century Cures Act and launched in 2018, is designed to accelerate the development and review of medical devices that may offer more effective diagnosis or treatment for life-threatening or irreversibly debilitating conditions. As of December 2025, the FDA has granted over 1,200 BDDs, [...]